Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection

Show other versions (1)

Bibliographic Details
Main Authors:	Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T
Format:	Journal article
Published:	2012

Similar Items

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.
by: Archary, D, et al.
Published: (2012)

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection
by: Archary, Derseree, et al.
Published: (2014)

Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
by: Archary, D, et al.
Published: (2012)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression.
by: Archary, D, et al.
Published: (2010)

Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
by: Murphy, M, et al.
Published: (2013)

Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Wright, J, et al.
Published: (2009)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Wright, J, et al.
Published: (2009)

Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.
by: Rolland, M, et al.
Published: (2010)

Spatial accessibility and the spread of HIV-1 subtypes and recombinants.
by: Tatem, A, et al.
Published: (2012)

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.
by: Leslie, A, et al.
Published: (2010)

Amino-Acid Co-Variation in HIV-1 Gag Subtype C: HLA-Mediated Selection Pressure and Compensatory Dynamics
by: Brander, Christian, et al.
Published: (2011)

Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
by: Wright, J, et al.
Published: (2010)

Revisiting the Influence of HLA-type, Frequency, HLA-supertype and Homozygosity on the Immune Control of HIV
by: Leslie, A, et al.
Published: (2008)

The global spread of HIV-1 subtype B epidemic.
by: Magiorkinis, G, et al.
Published: (2016)

Primary HIV-1 subtype C infection in Ethiopia.
by: Rinke de Wit, T, et al.
Published: (2002)

The global spread of HIV-1 subtype B epidemic
by: Magiorkinis, G, et al.
Published: (2016)

The impact of HIV-1 subtype on the clinical response on HAART.
by: Frater, J
Published: (2002)

Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.
by: Ndhlovu, Z, et al.
Published: (2011)

Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa
by: Farinre, Omotayo, et al.
Published: (2021)

Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
by: Wright, J, et al.
Published: (2011)

HIV-1 subtype C Nef-mediated SERINC5 down-regulation significantly contributes to overall Nef activity
by: Naicker, Delon, et al.
Published: (2023)

Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning
by: Igiraneza, AB, et al.
Published: (2024)

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.
by: Mann, J, et al.
Published: (2013)

Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
by: Lu, C.-L., et al.
Published: (2017)

Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.
by: Ramduth, D, et al.
Published: (2009)

HIV-1 subtype A gag variability and epitope evolution
by: Abidi, S, et al.
Published: (2014)

Lack of association between HLA class II alleles and in vitro replication capacities of recombinant viruses encoding HIV-1 subtype C Gag-protease from chronically infected individuals.
by: Wright, J, et al.
Published: (2012)

The changing epidemiological profile of HIV-1 subtype B epidemic in Ukraine
by: Vasylyeva, TI, et al.
Published: (2018)

Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.
by: Mureithi, M, et al.
Published: (2011)

Immunological Fingerprints of Controllers Developing Neutralizing HIV-1 Antibodies
by: Martin-Gayo, Enrique, et al.
Published: (2020)

Control of the HIV-1 load varies by viral subtype in a large cohort of African adults with incident HIV-1 infection
by: Price, M, et al.
Published: (2019)

Antibody neutralization of HIV-1 and the potential for vaccine design.
by: Sattentau, Q, et al.
Published: (1999)

Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.
by: Hemelaar, J, et al.
Published: (2006)

KIR-HLA footprints and NK cell-mediated recognition of HIV-1
by: Thobakgale, C, et al.
Published: (2012)

Neutralizing anti-HIV antibodies develop in a humanized
by: Seung, E., et al.
Published: (2013)

Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
by: Wright, J, et al.
Published: (2012)

Chapter 1 HLA-Mediated Control of HIV and HIV Adaptation to HLA
by: Payne, R, et al.
Published: (2009)

Humoral and Cellular Immune Pressures May Converge at the Base of the V3 Loop During Rwandan Subtype A HIV-1 Infection
by: Murphy, M, et al.
Published: (2011)